Mark E. Hester

2.9k citations

39 papers · 2.3k · 1 hit paper · h-index 23

Impact in

Developmental Neuroscience top 2%
- Neurogenesis and neuroplasticity mechanisms
Neurology top 2%
- Amyotrophic Lateral Sclerosis Research
- Neuroinflammation and Neurodegeneration Mechanisms

Papers in

Developmental Neuroscience 6
- Neurogenesis and neuroplasticity mechanisms 6
Pediatrics, Perinatology and Child Health 5
- Fetal and Pediatric Neurological Disorders 2

Co-authors: Brian K. Kaspar (9 shared papers)Carlos J. Miranda (4 shared papers)SungWon Song (3 shared papers)Lyndsey Braun (2 shared papers)Jerry R. Mendell (2 shared papers)Matthew J. Murtha (2 shared papers)Kathrin Meyer (2 shared papers)Kevin D. Foust (2 shared papers)
Journals: Molecular Therapy (3 papers)Cell Reports (2 papers)PLoS ONE (2 papers)Brain (2 papers)Proceedings of the National Academy of Sciences (2 papers)
Partner nations: United States United Kingdom Netherlands

In The Last Decade

Mark E. Hester

38 papers receiving 2.3k citations

Mark E. Hester's Hit Papers

align trajectories log scale

Astrocytes from familial and sporadic ALS patients are toxic to motor neurons 2011 · 666 citations

What are hit papers?

Paper score: A paper's citations measured against the top-1% bar of its own field and year: the square root of citations ÷ bar, so 1 means right at the bar and 2 means four times its citations. The bar blends the citation counts that enter the top 1% of the paper's subfields in its year (weighted 89.5%), of those subfields over all years (0.5%) and of its year across all fields (10%); a subfield and year with fewer than 400 papers takes its year's bar. Papers from 2026 are not scored yet: in an unfinished year, when a paper appeared matters more than how it is cited.

Hit paper: A paper cited at least 1.5× the top-1% bar of its field and year: a paper score of at least √1.5.

2011 Nature Biotechnology

Peers

Countries citing papers authored by Mark E. Hester

Since Specialization

Citations

This map shows the geographic impact of Mark E. Hester's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark E. Hester with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark E. Hester more than expected).

Fields of papers citing papers by Mark E. Hester

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark E. Hester. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark E. Hester. The network helps show where Mark E. Hester may publish in the future.

Co-authors

The 25 scholars most cited alongside Mark E. Hester, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark E. Hester Line = papers co-authored together Mark E. Hester links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 39 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Astrocytes from familial and sporadic ALS patients are toxic to motor neurons Nature Biotechnology ·Amanda M. Haidet-Phillips, Mark E. Hester, Carlos J. Miranda, Kathrin Meyer, Lyndsey Braun, SungWon Song, Shibi B. Likhite, Matthew J. Murtha Hit paper breakdown →	2011	666
2	Rapid and Efficient Generation of Functional Motor Neurons From Human Pluripotent Stem Cells Using Gene Delivered Transcription Factor Codes Molecular Therapy ·Mark E. Hester, Matthew J. Murtha, SungWon Song, Carlos J. Miranda, Kathrin Meyer, Jinbin Tian, Gabriella L. Boulting, David V. Schaffer	2011	159
3	Delivery of AAV-IGF-1 to the CNS Extends Survival in ALS Mice Through Modification of Aberrant Glial Cell Activity Molecular Therapy ·James C. Dodge, Amanda M. Haidet, Wendy Yang, Marco A. Passini, Mark E. Hester, Eric M. Roskelley, Christopher M. Treleaven, Liza Rizo	2008	144
4	Gene transfer demonstrates that muscle is not a primary target for non-cell-autonomous toxicity in familial amyotrophic lateral sclerosis Proceedings of the National Academy of Sciences ·Timothy M. Miller, Koji Yamanaka, Mark E. Hester, Priya Umapathi, Hannah A. Arnson, Liza Rizo, Jerry R. Mendell, Fred H. Gage	2006	134
5	Aging brain microenvironment decreases hippocampal neurogenesis through Wnt‐mediated survivin signaling Aging Cell ·Carlos J. Miranda, Lyndsey Braun, Yuying Jiang, Mark E. Hester, Ling Zhang, Matthew Riolo, Haijuan Wang, Rachel A. Altura	2012	128
6	Electrophysiological Maturation of Cerebral Organoids Correlates with Dynamic Morphological and Cellular Development Stem Cell Reports ·Summer Rose Fair, Dominic L. Julian, Annalisa M. Hartlaub, Sai Teja Pusuluri, Girik Malik, Taryn L. Summerfied, Guomao Zhao, Arelis B. Hester	2020	128
7	AAV4-mediated Expression of IGF-1 and VEGF Within Cellular Components of the Ventricular System Improves Survival Outcome in Familial ALS Mice Molecular Therapy ·James C. Dodge, Christopher M. Treleaven, Jonathan A. Fidler, Mark E. Hester, Amanda M. Haidet, Chalonda R. Handy, Amy Eagle, Jennifer Ann Cowger	2010	112
8	Spatially resolved transcriptomics reveals genes associated with the vulnerability of middle temporal gyrus in Alzheimer’s disease Acta Neuropathologica Communications ·Shuo Chen, Yuzhou Chang, Liangping Li, Diana M. Acosta, Yang Li, Qi Guo, Cankun Wang, Emir Turkes	2022	94
9	Short-read, high-throughput sequencing technology for STR genotyping BioTechniques ·Daniel M. Bornman, Mark E. Hester, Jared Schuetter, Manjula Kasoji, Angela T. Minard-Smith, Curt A Barden, Gene D. Godbold, Christine H. Baker	2012	83
10	Maternal high fat diet exposure is associated with increased hepcidin levels, decreased myelination, and neurobehavioral changes in male offspring Brain Behavior and Immunity ·Amanda E. Graf, Scott W. Lallier, Gavisha Waidyaratne, Michael David Thompson, Trent E. Tipple, Mark E. Hester, Aaron J. Trask, Lynette Kay Rogers	2016	69
11	Two Factor Reprogramming of Human Neural Stem Cells into Pluripotency PLoS ONE ·Mark E. Hester, SungWon Song, Carlos J. Miranda, Amy Eagle, Phillip H. Schwartz, Brian K. Kaspar	2009	60
12	Single-cell RNA sequencing reveals immunosuppressive myeloid cell diversity during malignant progression in a murine model of glioma Cell Reports ·Sakthi Harini Rajendran, Yang Hu, Alessandro Canella, Clayton R. Peterson, Amy C. Gross, Maren Cam, Matthew Nazzaro, Abigail Haffey	2023	47
13	Smad2 and Smad3 coordinately regulate craniofacial and endodermal development Developmental Biology ·Ye Liu, Maria H. Festing, Mark E. Hester, Scott A. Rankin, Heithem M. El‐Hodiri, Aaron M. Zorn, Michael B. Weinstein +1 other	2004	44
14	AAV as a Gene Transfer Vector for the Treatment of Neurological Disorders: Novel Treatment Thoughts for ALS Current Gene Therapy ·Mark E. Hester, Kevin D. Foust, Rita Wen Kaspar, Brian K. Kaspar	2009	41
15	Acetylcholine negatively regulates development of the neuromuscular junction through distinct cellular mechanisms Proceedings of the National Academy of Sciences ·Mahru C. An, Weichun Lin, Jiefei Yang, Bertha Dominguez, Daniel Padgett, Yoshie Sugiura, Prafulla Aryal, Thomas W. Gould	2010	41
16	Cerebral organoids containing an AUTS2 missense variant model microcephaly Brain ·Summer Rose Fair, Wesley N. Schwind, Dominic L. Julian, Alecia Biel, Gongbo Guo, Ryan Rutherford, Swetha Ramadesikan, Jesse J. Westfall	2022	40
17	Modeling neurodegenerative diseases with cerebral organoids and other three-dimensional culture systems: focus on Alzheimer’s disease Stem Cell Reviews and Reports ·Lalitha Venkataraman, Summer Rose Fair, Craig A. McElroy, Mark E. Hester, Hongjun Fu	2020	39
18	Newly identified disorder of copper metabolism caused by variants in CTR1, a high-affinity copper transporter Human Molecular Genetics ·Spyros P. Batzios, Galit Tal, Andrew T DiStasio, Yanyan Peng, Christiana Charalambous, Paola Nicolaides, Erik‐Jan Kamsteeg, Stanley H. Korman	2022	35
19	AUTS2 Syndrome: Molecular Mechanisms and Model Systems Frontiers in Molecular Neuroscience ·Alecia Biel, Anthony S. Castanza, Ryan Rutherford, Summer Rose Fair, Lincoln Chifamba, Jason C. Wester, Mark E. Hester, Robert F. Hevner	2022	29
20	PTEN somatic mutations contribute to spectrum of cerebral overgrowth Brain ·Daniel C. Koboldt, Katherine E. Miller, Anthony R. Miller, Jocelyn M. Bush, Sean D McGrath, Kristen Leraas, Erin R. Crist, Summer Rose Fair	2021	28

About Mark E. Hester

Mark E. Hester is a scholar working on Developmental Neuroscience, Pediatrics, Perinatology and Child Health, Neurology, Molecular Biology and Genetics, having authored 39 papers that have together received 2.3k indexed citations. Recurring topics across this work include Pluripotent Stem Cells Research (7 papers), Neurogenesis and neuroplasticity mechanisms (6 papers), Amyotrophic Lateral Sclerosis Research (5 papers), Alzheimer's disease research and treatments (3 papers), TGF-β signaling in diseases (3 papers), Genetics and Neurodevelopmental Disorders (3 papers), CRISPR and Genetic Engineering (3 papers) and Fetal and Pediatric Neurological Disorders (2 papers). The work is most often cited by research in Developmental Neuroscience (203 citations), Neurology (741 citations), Neurology (176 citations), Genetics (98 citations) and Cellular and Molecular Neuroscience (167 citations). Mark E. Hester has collaborated with scholars based in United States, United Kingdom and Netherlands. Frequent co-authors include Brian K. Kaspar, Carlos J. Miranda, SungWon Song, Lyndsey Braun, Jerry R. Mendell, Matthew J. Murtha, Kathrin Meyer, Kevin D. Foust, Anja Kammesheidt and Arthur H.M. Burghes. Their work appears in journals such as Molecular Therapy, Cell Reports, PLoS ONE, Brain and Proceedings of the National Academy of Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Mark E. Hester

Impact in

Papers in i

In The Last Decade

Mark E. Hester

Mark E. Hester's Hit Papers

Peers

Countries citing papers authored by Mark E. Hester

Fields of papers citing papers by Mark E. Hester

All Works

About Mark E. Hester

Explore authors with similar magnitude of impact

Papers in